78.59 USD
-2.49 (-3.07%)
78.59 USD
0 (0%)
Overall RDNT gets a fundamental rating of 3 out of 10. We evaluated RDNT against 101 industry peers in the Health Care Providers & Services industry. While RDNT is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, RDNT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year RDNT was profitable.
RDNT had a positive operating cash flow in the past year.
RDNT had positive earnings in 4 of the past 5 years.
Each year in the past 5 years RDNT had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -0.35%, RDNT perfoms like the industry average, outperforming 48.51% of the companies in the same industry.
Looking at the Return On Equity, with a value of -1.20%, RDNT is in line with its industry, outperforming 53.47% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 2.08%, RDNT is in line with its industry, outperforming 45.54% of the companies in the same industry.
RDNT had an Average Return On Invested Capital over the past 3 years of 2.96%. This is significantly below the industry average of 9.22%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.35% | ||
| ROE | -1.2% | ||
| ROIC | 2.08% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
1.3 Margins
RDNT's Profit Margin has declined in the last couple of years.
RDNT's Operating Margin of 3.96% is in line compared to the rest of the industry. RDNT outperforms 58.42% of its industry peers.
In the last couple of years the Operating Margin of RDNT has remained more or less at the same level.
RDNT has a Gross Margin of 21.33%. This is comparable to the rest of the industry: RDNT outperforms 45.54% of its industry peers.
RDNT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.96% | ||
| PM (TTM) | N/A | ||
| GM | 21.33% |
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
RDNT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
RDNT has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, RDNT has more shares outstanding
The debt/assets ratio for RDNT is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.18 indicates that RDNT is not a great score, but indicates only limited risk for bankruptcy at the moment.
RDNT has a Altman-Z score (2.18) which is comparable to the rest of the industry.
The Debt to FCF ratio of RDNT is 21.06, which is on the high side as it means it would take RDNT, 21.06 years of fcf income to pay off all of its debts.
RDNT has a Debt to FCF ratio of 21.06. This is in the lower half of the industry: RDNT underperforms 60.40% of its industry peers.
RDNT has a Debt/Equity ratio of 1.01. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of RDNT (1.01) is worse than 61.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.01 | ||
| Debt/FCF | 21.06 | ||
| Altman-Z | 2.18 |
ROIC/WACC0.23
WACC9.11%
2.3 Liquidity
A Current Ratio of 1.87 indicates that RDNT should not have too much problems paying its short term obligations.
RDNT's Current ratio of 1.87 is fine compared to the rest of the industry. RDNT outperforms 75.25% of its industry peers.
A Quick Ratio of 1.87 indicates that RDNT should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.87, RDNT is in the better half of the industry, outperforming 79.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.87 | ||
| Quick Ratio | 1.87 |
3. Growth
3.1 Past
The earnings per share for RDNT have decreased strongly by -37.70% in the last year.
The Earnings Per Share has been growing by 16.79% on average over the past years. This is quite good.
Looking at the last year, RDNT shows a quite strong growth in Revenue. The Revenue has grown by 11.09% in the last year.
The Revenue has been growing by 9.65% on average over the past years. This is quite good.
EPS 1Y (TTM)-37.7%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%11.11%
Revenue 1Y (TTM)11.09%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%13.39%
3.2 Future
RDNT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.27% yearly.
Based on estimates for the next years, RDNT will show a quite strong growth in Revenue. The Revenue will grow by 10.97% on average per year.
EPS Next Y-34.83%
EPS Next 2Y17.9%
EPS Next 3Y20.1%
EPS Next 5Y19.27%
Revenue Next Year8.63%
Revenue Next 2Y8.59%
Revenue Next 3Y7.93%
Revenue Next 5Y10.97%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 206.82, the valuation of RDNT can be described as expensive.
Based on the Price/Earnings ratio, RDNT is valued a bit more expensive than the industry average as 60.40% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 26.46. RDNT is valued rather expensively when compared to this.
RDNT is valuated quite expensively with a Price/Forward Earnings ratio of 89.74.
RDNT's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. RDNT is more expensive than 62.38% of the companies in the same industry.
RDNT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 36.10.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 206.82 | ||
| Fwd PE | 89.74 |
4.2 Price Multiples
RDNT's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as RDNT.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 116.47 | ||
| EV/EBITDA | 36.43 |
4.3 Compensation for Growth
RDNT's earnings are expected to grow with 20.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)12.32
EPS Next 2Y17.9%
EPS Next 3Y20.1%
5. Dividend
5.1 Amount
RDNT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
78.59
-2.49 (-3.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.04%
Inst Owner Change6.21%
Ins Owners13.02%
Ins Owner Change-1.17%
Market Cap6.06B
Revenue(TTM)1.97B
Net Income(TTM)-12.71M
Analysts86.15
Price Target93.55 (19.04%)
Short Float %10.55%
Short Ratio9.76
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)40.87%
Min EPS beat(2)-12.24%
Max EPS beat(2)93.99%
EPS beat(4)2
Avg EPS beat(4)-18.47%
Min EPS beat(4)-161.6%
Max EPS beat(4)93.99%
EPS beat(8)5
Avg EPS beat(8)155.06%
EPS beat(12)7
Avg EPS beat(12)122.76%
EPS beat(16)8
Avg EPS beat(16)-190.67%
Revenue beat(2)1
Avg Revenue beat(2)1.79%
Min Revenue beat(2)-0.11%
Max Revenue beat(2)3.68%
Revenue beat(4)3
Avg Revenue beat(4)2.28%
Min Revenue beat(4)-0.11%
Max Revenue beat(4)4.27%
Revenue beat(8)7
Avg Revenue beat(8)2%
Revenue beat(12)11
Avg Revenue beat(12)2.45%
Revenue beat(16)12
Avg Revenue beat(16)1.41%
PT rev (1m)6.49%
PT rev (3m)14.53%
EPS NQ rev (1m)-3.48%
EPS NQ rev (3m)-3.17%
EPS NY rev (1m)0%
EPS NY rev (3m)13.61%
Revenue NQ rev (1m)1.5%
Revenue NQ rev (3m)1.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 206.82 | ||
| Fwd PE | 89.74 | ||
| P/S | 3.08 | ||
| P/FCF | 116.47 | ||
| P/OCF | 23.58 | ||
| P/B | 5.73 | ||
| P/tB | 57.15 | ||
| EV/EBITDA | 36.43 |
EPS(TTM)0.38
EY0.48%
EPS(NY)0.88
Fwd EY1.11%
FCF(TTM)0.67
FCFY0.86%
OCF(TTM)3.33
OCFY4.24%
SpS25.53
BVpS13.72
TBVpS1.38
PEG (NY)N/A
PEG (5Y)12.32
Graham Number10.83
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.35% | ||
| ROE | -1.2% | ||
| ROCE | 2.52% | ||
| ROIC | 2.08% | ||
| ROICexc | 2.81% | ||
| ROICexgc | 4.81% | ||
| OM | 3.96% | ||
| PM (TTM) | N/A | ||
| GM | 21.33% | ||
| FCFM | 2.64% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
ROICexc(3y)3.61%
ROICexc(5y)3.42%
ROICexgc(3y)6.03%
ROICexgc(5y)5.63%
ROCE(3y)3.6%
ROCE(5y)3.56%
ROICexgc growth 3Y-3.51%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-4.28%
ROICexc growth 5Y-1.4%
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
F-Score3
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.01 | ||
| Debt/FCF | 21.06 | ||
| Debt/EBITDA | 5.96 | ||
| Cap/Depr | 201.55% | ||
| Cap/Sales | 10.41% | ||
| Interest Coverage | 0.9 | ||
| Cash Conversion | 143.12% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.87 | ||
| Quick Ratio | 1.87 | ||
| Altman-Z | 2.18 |
F-Score3
WACC9.11%
ROIC/WACC0.23
Cap/Depr(3y)125.7%
Cap/Depr(5y)126.7%
Cap/Sales(3y)9.85%
Cap/Sales(5y)9.84%
Profit Quality(3y)1105%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.7%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%11.11%
EPS Next Y-34.83%
EPS Next 2Y17.9%
EPS Next 3Y20.1%
EPS Next 5Y19.27%
Revenue 1Y (TTM)11.09%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%13.39%
Revenue Next Year8.63%
Revenue Next 2Y8.59%
Revenue Next 3Y7.93%
Revenue Next 5Y10.97%
EBIT growth 1Y-30.9%
EBIT growth 3Y5.38%
EBIT growth 5Y8.53%
EBIT Next Year113.89%
EBIT Next 3Y40.5%
EBIT Next 5Y34.69%
FCF growth 1Y85.26%
FCF growth 3Y90.52%
FCF growth 5Y8.35%
OCF growth 1Y38.64%
OCF growth 3Y15.95%
OCF growth 5Y17.44%
RADNET INC / RDNT FAQ
Can you provide the ChartMill fundamental rating for RADNET INC?
ChartMill assigns a fundamental rating of 3 / 10 to RDNT.
What is the valuation status of RADNET INC (RDNT) stock?
ChartMill assigns a valuation rating of 1 / 10 to RADNET INC (RDNT). This can be considered as Overvalued.
How profitable is RADNET INC (RDNT) stock?
RADNET INC (RDNT) has a profitability rating of 4 / 10.
What is the earnings growth outlook for RADNET INC?
The Earnings per Share (EPS) of RADNET INC (RDNT) is expected to decline by -34.83% in the next year.